Dinalbuphine Sebacate in Postoperative Pain Control After TKA (NCT07140510) | Clinical Trial Compass
Not Yet RecruitingPhase 4
Dinalbuphine Sebacate in Postoperative Pain Control After TKA
Thailand100 participantsStarted 2025-10
Plain-language summary
To evaluate the effectiveness of Dinalbuphine Sebacate for controlling subacute pain after total knee arthroplasty
Who can participate
Age range
50 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Osteoarthritic knee patients underwent unilateral primary TKA
* Age 50-90 years
* ASA class I-III
* Participants understand and consent to the protocol of the trial
Exclusion Criteria:
* Morbid obesity (BMI\>40)
* Knee osteoarthritis from inflammatory knee arthritis, trauma, infection
* Previous knee surgery
* Cognitive disorder
* Liver disease
* Allergy to NSAIDs, opioids, sesame oil, and benzyl benzoate
* CYP3A4 inhibitor and inducer drugs used
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual analog scale for pain (VAS 0-100)
Timeframe: Record every 12 hours after surgery until 2 weeks postoperatively, then once weekly until 12 weeks postopertively